4th January 2022
Consilium Strategic Communications strengthens team with three new appointments
Namrata Taak, Giulia Lasagni and Andrew Stern join Consilium to continue the firm’s growth as a leading global healthcare-focused financial PR and IR advisor
London, 4 January 2022. Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to announce it has strengthened its team with the appointment of Namrata Taak as Senior Associate Partner and Giulia Lasagni and Andrew Stern as Associate Partners. The new appointments will be working from the Consilium’s headquarters in the City of London.
Commenting on the new appointments, Mary-Jane Elliott, Managing Partner of Consilium Strategic Communications, said: “As a leading global healthcare specialist PR and IR advisor, Consilium’s goal is to provide excellent advice and service to our clients. Throughout 2021, we continued to build the business around our team of highly experienced and energised staff, especially as demand for our work increases and I am delighted to be continuing this as we kick off the year.
“Namrata, Giulia and Andrew bring leading global pharma, international media and US medical device experience, respectively, to our growing team. We are proud to be able to call on this strong knowledge base to support our loyal clients – many of whom are playing a role in bringing vaccines, tests and potential treatments forward to help society during the pandemic.”
Namrata Taak, Senior Associate Partner
Namrata brings over 20 years’ in-house healthcare experience with a unique blend of corporate, scientific and medical communications across a broad range of therapy areas including immuno-inflammation, global health and rare diseases. At her last in-house role, Namrata was Director of Pipeline and Product Communications at GSK where she has worked with a diverse group of internal and external stakeholders. Collaborating closely with senior business leaders, media, investor relations, digital and partners, she oversaw the development and execution of multi-channel strategic communication plans. Namrata holds a degree in Microbiology from King’s College London. Contact Namrata on E-mail: Taak@consilum-comms.com
Giulia Lasagni, Associate Partner
Giulia joined Consilium in November 2021 after working for almost 10 years as a financial journalist in London. She was most recently an assistant editor at Acuris (formerly Mergermarket Group), where she reported on M&A and ECM deals across Europe and coordinated the coverage of shareholder activism and ESG. She previously covered financial technology and the hedge funds industry. Giulia holds a PhD in political history from the University of Bologna and a master's degree in public affairs reporting from Northwestern University's Medill School of Journalism. A native of Italy, she was a student at Sciences Po Paris and is fluent in French. Contact Giulia on E-mail: Lasagni@consilium-comms.com
Andrew Stern, Associate Partner
Andrew is an experienced public relations professional with deep roots in the US media landscape.
Andrew joins Consilium from Cardinal Health, where he advised on strategy and led execution efforts across the entire Cardinal Health external affairs portfolio. Previously, he worked on PR campaigns across a broad spectrum of industries including retail, food and beverage, and healthcare both in-house and in an agency environment. Andrew also has an expansive background in advertising planning and buying from his time at Starcom Worldwide. Andrew holds a degree in Strategic Communication from The Ohio State University in the United States. Contact Andrew on E-mail: Stern@consilium-comms.com
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. Consilium's team, based in both Europe and US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, international media management, transactions and healthcare stakeholder challenges. Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
For more information please see www.consilium-comms.com